Show Stocks and Investing Publications • Thu, August 8, 2024
Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $19 on, Aug 8th, 2024
inke-maintained-ccrn-at-buy-with-decreased-target-to-19-on-aug-8th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIKevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $21 to $19 on, Aug 8th, 2024.
Kevin has made no other calls on CCRN in the last 4 months.
There are 2 other peers that have a rating on CCRN. Out of the 2 peers that are also analyzing CCRN, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tobey Sommer of "Truist Securities" Maintained at Hold with Increased Target to $17 on, Thursday, August 1st, 2024
This is the rating of the analyst that currently disagrees with Kevin
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $19 on, Thursday, May 2nd, 2024
Like: 👍